共 254 条
[1]
Barnham KJ(2006)Delineating common molecular mechanisms in Alzheimer’s and prion diseases Trends Biochem Sci 31 465-472
[2]
Cappai R(2005)Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein Proc Natl Acad Sci USA 102 1430-1435
[3]
Beyreuther K(2008)Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine Acta Neuropathol 115 193-203
[4]
Masters CL(2005)Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway Faseb J 19 1377-1379
[5]
Hill AF(2008)In vivo alpha-synuclein overexpression in rodents: a useful model of Parkinson’s disease? Exp Neurol 209 22-27
[6]
Bertoncini CW(2000)Acceleration of oligomerisation, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson’s disease: implications for pathogenesis and therapy Proc Natl Acad Sci USA 97 571-576
[7]
Jung YS(2001)Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct Science 294 1346-1349
[8]
Fernandez CO(2005)Structure and properties of alpha-synuclein and other amyloids determined at the amino acid level Proc Natl Acad Sci USA 102 15477-15482
[9]
Hoyer W(1998)Effects of the mutations Ala FEBS Lett 440 67-70
[10]
Griesinger C(2004) to Pro and Ala Proc Natl Acad Sci USA 101 12497-12502